Boston Scientific Corp. (BSX) Tops Q2 EPS by 8c; Raises FY11 Outlook Above Street, Guides Q3
Tweet Send to a Friend
Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
